|Videos|October 17, 2017

River of Life Fundraising Initiative

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Jennie Smythe

Finding Strength and Advocacy During Breast Cancer Awareness Month

October 1st 2025

FDA sign image

All FDA Oncology Approvals From September 2025

BySpencer Feldman

October 1st 2025

Dr. Angela DeMichele

New Strategy May Prevent Breast Cancer Relapse

BySpencer Feldman

September 30th 2025

Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea

September 30th 2025

Enhertu improved invasive disease-free survival versus Kadcyla in high-risk HER2+ early breast cancer: © stock.adobe.com.

Enhertu Improves Invasive Disease-Free Survival in HER2+ Early Breast Cancer

September 29th 2025

Trending on CURE

New Strategy May Prevent Breast Cancer Relapse

FDA Approves Enoby and Xtrenbo Biosimilars for Bone Health and Cancer Care

All FDA Oncology Approvals From September 2025

Understanding the Evolving Role of a Pathologist in Lung Cancer Care

Positive Experience With TAR-200 for Recurrent Bladder Cancer

© 2025 MJH Life Sciences^®

All rights reserved.